Published in Mol Cell Proteomics on February 25, 2011
The ubiquitin proteasome system in human cardiomyopathies and heart failure. Am J Physiol Heart Circ Physiol (2013) 0.99
The ubiquitin-proteasome system and cardiovascular disease. Prog Mol Biol Transl Sci (2012) 0.93
The ubiquitin proteasome system and myocardial ischemia. Am J Physiol Heart Circ Physiol (2012) 0.90
Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. Am J Physiol Heart Circ Physiol (2012) 0.87
Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies. Antioxid Redox Signal (2014) 0.85
A novel spectral library workflow to enhance protein identifications. J Proteomics (2013) 0.80
Novel epigenetic-based therapies useful in cardiovascular medicine. World J Cardiol (2016) 0.77
Characterizing the dynamics of proteasome complexes by proteomics approaches. Antioxid Redox Signal (2014) 0.77
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem (1996) 10.70
Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol Biol Cell (2000) 5.19
The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol Cell Biol (1998) 4.63
Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell (2004) 3.84
An integrated mass spectrometry-based proteomic approach: quantitative analysis of tandem affinity-purified in vivo cross-linked protein complexes (QTAX) to decipher the 26 S proteasome-interacting network. Mol Cell Proteomics (2005) 2.62
Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation (2006) 2.50
Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry (2007) 2.43
Hsm3/S5b participates in the assembly pathway of the 19S regulatory particle of the proteasome. Mol Cell (2009) 2.35
Mapping the murine cardiac 26S proteasome complexes. Circ Res (2006) 2.17
Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. J Biol Chem (1994) 2.15
Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome. Mol Cell (2010) 2.13
Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem (2001) 1.97
Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ Res (2006) 1.81
Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation. J Biol Chem (2008) 1.75
Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice. J Mol Cell Cardiol (2010) 1.61
The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome. EMBO J (2003) 1.58
Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci U S A (1999) 1.56
Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys (2002) 1.52
Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol (2000) 1.52
Purification of proteasomes, proteasome subcomplexes, and proteasome-associated proteins from budding yeast. Methods Mol Biol (2005) 1.48
Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteomics (2007) 1.41
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol (2002) 1.37
Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys (2004) 1.36
Identification of a peptoid inhibitor of the proteasome 19S regulatory particle. J Am Chem Soc (2007) 1.36
LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem Biol (2007) 1.35
The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation (2007) 1.34
O-GlcNAc modification: a nutritional sensor that modulates proteasome function. Trends Cell Biol (2004) 1.33
Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. BMC Cancer (2006) 1.33
Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. Biochemistry (2001) 1.32
Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues. Mol Cell Proteomics (2008) 1.29
Molecular characterization of the "26S" proteasome complex from rat liver. J Struct Biol (1994) 1.28
Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system. Hypertension (2007) 1.26
Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol (2008) 1.23
Protein quality control and degradation in cardiomyocytes. J Mol Cell Cardiol (2008) 1.22
Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys (2006) 1.20
PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts. J Mol Cell Cardiol (2008) 1.20
Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach. Mol Cell Proteomics (2008) 1.19
20S proteasome differentially alters translation of different mRNAs via the cleavage of eIF4F and eIF3. Mol Cell (2004) 1.16
Purification of PA700, the 19S regulatory complex of the 26S proteasome. Methods Enzymol (2005) 1.16
Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J (2008) 1.14
Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity. Mol Cell Proteomics (2008) 1.13
The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control. Cardiovasc Pathol (2009) 1.11
Retracted Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am J Physiol Heart Circ Physiol (2005) 1.08
Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics (2005) 1.08
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits. Cancer (2008) 1.07
Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors. Cardiovasc Res (2009) 1.07
Hsp90 enhances degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem (2004) 1.07
Retracted Cardioprotection with palm oil tocotrienols: comparision of different isomers. Am J Physiol Heart Circ Physiol (2007) 1.05
Rapid identification of the pharmacophore in a peptoid inhibitor of the proteasome regulatory particle. Chem Commun (Camb) (2008) 0.98
Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency. Endocrinology (2008) 0.95
Oxidative injury induces selective rather than global inhibition of proteasomal activity. J Mol Cell Cardiol (2007) 0.90
Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am J Pathol (2006) 0.88
Recognition and processing of misfolded proteins by PA700, the 19S regulatory complex of the 26S proteasome. Methods Mol Biol (2005) 0.87
The murine cardiac 26S proteasome: an organelle awaiting exploration. Ann N Y Acad Sci (2005) 0.84
The 19S proteasome positively regulates histone methylation at cytokine inducible genes. Biochim Biophys Acta (2009) 0.84
Conformational changes in the 20S proteasome upon macromolecular ligand binding analyzed with monoclonal antibodies. Arch Biochem Biophys (1999) 0.81
The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol (2007) 10.24
Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res (2009) 3.77
A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science (2007) 3.73
Role of the mitochondrial permeability transition in myocardial disease. Circ Res (2003) 3.26
The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating. Proc Natl Acad Sci U S A (2008) 2.82
BioJS: an open source JavaScript framework for biological data visualization. Bioinformatics (2013) 2.53
Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res (2003) 2.52
Mapping the murine cardiac 26S proteasome complexes. Circ Res (2006) 2.17
Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol (2008) 1.89
Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ Res (2006) 1.81
Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci (2005) 1.75
Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation (2013) 1.69
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Crystal packing analysis of murine VDAC1 crystals in a lipidic environment reveals novel insights on oligomerization and orientation. Channels (Austin) (2009) 1.57
Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol Cell Proteomics (2012) 1.53
Systematic characterization of the murine mitochondrial proteome using functionally validated cardiac mitochondria. Proteomics (2008) 1.51
Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol (2004) 1.51
Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol Cell Proteomics (2002) 1.44
Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury. J Mol Cell Cardiol (2008) 1.44
Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics (2010) 1.41
Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteomics (2007) 1.41
Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest (2009) 1.36
Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy. Circ Res (2010) 1.34
Loss of ABCG1 results in chronic pulmonary inflammation. J Immunol (2008) 1.32
Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci (2004) 1.31
Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues. Mol Cell Proteomics (2008) 1.29
Post-translational modifications of integral membrane proteins resolved by top-down Fourier transform mass spectrometry with collisionally activated dissociation. Mol Cell Proteomics (2010) 1.28
Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: modulation by nitric oxide. Circ Res (2008) 1.24
2-DE with IPGs. Electrophoresis (2009) 1.20
Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach. Mol Cell Proteomics (2008) 1.19
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol (2006) 1.19
Altered proteome biology of cardiac mitochondria under stress conditions. J Proteome Res (2008) 1.16
Integration of cardiac proteome biology and medicine by a specialized knowledgebase. Circ Res (2013) 1.15
Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol (2013) 1.14
ABCC6 localizes to the mitochondria-associated membrane. Circ Res (2012) 1.14
Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J Mol Cell Cardiol (2008) 1.13
Functional proteomic analysis of a three-tier PKCepsilon-Akt-eNOS signaling module in cardiac protection. Am J Physiol Heart Circ Physiol (2004) 1.11
PKCepsilon activation augments cardiac mitochondrial respiratory post-anoxic reserve--a putative mechanism in PKCepsilon cardioprotection. J Mol Cell Cardiol (2005) 1.08
HLA ligand profiles of primary renal cell carcinoma maintained in metastases. Cancer Immunol Immunother (2009) 1.08
Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte. Circ Res (2010) 1.08
Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics (2005) 1.08
Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production. J Mol Cell Cardiol (2002) 1.06
Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights. Mol Cell Proteomics (2006) 1.06
Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res (2006) 1.02
Substrate- and isoform-specific proteome stability in normal and stressed cardiac mitochondria. Circ Res (2012) 1.02
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol Cell Proteomics (2009) 1.01
Mitochondrial permeability transition in cardiac cell injury and death. Cardiovasc Drugs Ther (2006) 1.01
Scaffold proteins and assembly of multiprotein signaling complexes. J Mol Cell Cardiol (2004) 1.00
Protein kinetic signatures of the remodeling heart following isoproterenol stimulation. J Clin Invest (2014) 0.99
Plant defensins: defense, development and application. Plant Signal Behav (2009) 0.99
Exploring proteasome complexes by proteomic approaches. Proteomics (2007) 0.98
Protein degradation by the 26S proteasome system in the normal and stressed myocardium. Antioxid Redox Signal (2006) 0.98
Large scale analysis of MASCOT results using a Mass Accuracy-based THreshold (MATH) effectively improves data interpretation. J Proteome Res (2005) 0.97
Subproteomic study of hepatitis C virus replicon reveals Ras-GTPase-activating protein binding protein 1 as potential HCV RC component. Biochem Biophys Res Commun (2006) 0.96
An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. J Proteomics (2012) 0.96
Sheathless capillary electrophoresis-tandem mass spectrometry for top-down characterization of Pyrococcus furiosus proteins on a proteome scale. Anal Chem (2014) 0.95
Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy. Mol Cell Proteomics (2010) 0.95
Characterization, design, and function of the mitochondrial proteome: from organs to organisms. J Proteome Res (2013) 0.94
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). Mol Cell Proteomics (2011) 0.94
Data-Driven Approach To Determine Popular Proteins for Targeted Proteomics Translation of Six Organ Systems. J Proteome Res (2016) 0.93
Regulation of ubiquitin-dependent cargo sorting by multiple endocytic adaptors at the plasma membrane. Proc Natl Acad Sci U S A (2013) 0.93
A defensin from tomato with dual function in defense and development. Plant Mol Biol (2009) 0.93
Understanding proteasome assembly and regulation: importance to cardiovascular medicine. Trends Cardiovasc Med (2008) 0.92
Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands. J Proteome Res (2009) 0.92
Past and present course of cardioprotection against ischemia-reperfusion injury. J Appl Physiol (1985) (2007) 0.92
Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Mol Cell Proteomics (2013) 0.91
Myocardial infarction in mice alters sarcomeric function via post-translational protein modification. Mol Cell Biochem (2011) 0.91
Molecular conformation dictates signaling module formation: example of PKCepsilon and Src tyrosine kinase. Am J Physiol Heart Circ Physiol (2002) 0.91
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). J Proteome Res (2011) 0.91